An enduring challenge is figuring out why patients appear to have resistant hypertension and how to cure them of it.
Readers address insulin dosing and propose going further on climate change.
This column reviews a recall of an oral liquid docusate sodium solution because of contamination and of an international normalized ratio monitoring system because it may provide significantly lower results than another method.
Darilyn Moyer, MD, FACP, ACP's first female EVP/CEO, addresses her plans for the organization, the evolution of health care, and how her experience will guide her efforts.
George M. Abraham, MD, MPH, FACP, and Gregory C. Kane, MD, FACP, are seeking election as Chair-elect Designee of the Board of Governors. The Governors will be casting ballots next month, and the results will be announced in late October.
A 35-year-old woman is evaluated for worsening thrombocytopenia; she is pregnant at 36 weeks' gestation. Medical history is significant for immune thrombocytopenic purpura. Previous platelet counts during this pregnancy have been 80,000 to 100,000/##mu;L (80-100 x 109/L). Her only medication is a prenatal vitamin. Following a physical exam and lab results, what is the most appropriate management of this patient's thrombocytopenia?